McKesson Corporation logo
McKesson Corporation (MCK)
Compare

McKesson Corporation (MCK) EV/Sales Ratio: 0.24x

popular:market cap|pe ratio|revenue|price history|total return

Is McKesson Corporation’s EV/Sales ratio high or low?

McKesson Corporation's EV/Sales ratio of 0.24x is in line with its 5-year average of 0.23x, around the middle of its 5-year range (0.14x–0.32x).

As of Friday, June 19, 2026. 11.64% below its 12-month average of 0.27x.

EV/EBITDA|P/S Ratio|Revenue|All Metrics

MCK EV/Sales Ratio Chart

MCK EV/Sales Ratio
0.24x-7.69% 1Y
Zoom

MCK Average EV/Sales Ratio Chart

MCK Current vs Average EV/Sales Ratio Chart

MCK EV/Sales Ratio Metrics

EV/SALES RATIO

0.24x

EV/SALES RATIO AVG TTM

0.27x

EV/SALES RATIO AVG 3Y

0.25x

EV/SALES RATIO AVG 5Y

0.23x

EV/SALES RATIO AVG 10Y

0.20x

EV/SALES RATIO AVG 15Y

0.22x

EV/SALES RATIO AVG 20Y

0.20x

CURRENT VS TTM AVG

-11.64%

CURRENT VS 3Y AVG

-5.04%

CURRENT VS 5Y AVG

+4.52%

CURRENT VS 10Y AVG

+20.70%

CURRENT VS 15Y AVG

+10.00%

CURRENT VS 20Y AVG

+19.01%

MCK Competitors' EV/Sales Ratio

NAMEMARKET CAPEV/SALES RATIOTTM3Y5Y
McKesson Corporation (MCK)$87.88B0.24x0.27x0.25x0.23x
Elevance Health Inc. (ELV)vs ›$84.37B0.54x0.51x0.67x0.76x
HCA Healthcare, Inc. (HCA)vs ›$84.08B1.79x2.05x1.95x1.92x
Medtronic plc (MDT)vs ›$101.86B3.53x4.19x4.18x4.52x
Cigna Corporation (CI)vs ›$73.88B0.35x0.38x0.50x0.55x
Boston Scientific Corporation (BSX)vs ›$67.35B3.72x7.33x7.78x7.06x
Bristol-Myers Squibb Company (BMY)vs ›$110.27B3.00x2.99x3.12x3.47x
Regeneron Pharmaceuticals, Inc. (REGN)vs ›$62.84B4.39x5.04x6.55x6.19x
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$114.63B9.16x9.41x10.00x9.08x
Stryker Corporation (SYK)vs ›$119.03B5.09x6.27x6.58x6.44x

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

  • It works for unprofitable companies where P/E doesn't apply
  • Revenue is harder to manipulate than earnings
  • It supports comparisons across companies at different profitability stages
  • It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

McKesson Corporation EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

McKesson Corporation EV/Sales Ratio FAQ

What is the EV/Sales ratio for McKesson Corporation (MCK)?
The EV/Sales ratio for MCK stock is 0.24x.
Is McKesson Corporation's EV/Sales ratio high or low?
McKesson Corporation's EV/Sales ratio of 0.24x is in line with its 5-year average of 0.23x, around the middle of its 5-year range (0.14x–0.32x).
What is the TTM average EV/Sales ratio for McKesson Corporation (MCK)?
The TTM average EV/Sales ratio for MCK stock is 0.27x.
What is the 3Y average EV/Sales ratio for McKesson Corporation (MCK)?
The 3Y average EV/Sales ratio for MCK stock is 0.25x.
What is the 5Y average EV/Sales ratio for McKesson Corporation (MCK)?
The 5Y average EV/Sales ratio for MCK stock is 0.23x.
What is the 10Y average EV/Sales ratio for McKesson Corporation (MCK)?
The 10Y average EV/Sales ratio for MCK stock is 0.20x.
What is the 15Y average EV/Sales ratio for McKesson Corporation (MCK)?
The 15Y average EV/Sales ratio for MCK stock is 0.22x.
What is the 20Y average EV/Sales ratio for McKesson Corporation (MCK)?
The 20Y average EV/Sales ratio for MCK stock is 0.20x.

McKesson Corporation EV/Sales Ratio History

DATEEV/SALES RATIO
2026-06-180.24x
2026-06-170.25x
2026-06-160.25x
2026-06-150.25x
2026-06-120.25x
2026-06-110.25x
2026-06-100.25x
2026-06-090.25x
2026-06-080.24x
2026-06-050.25x
2026-06-040.24x
2026-06-030.24x
2026-06-020.24x
2026-06-010.23x
2026-05-290.24x
2026-05-280.24x
2026-05-270.24x
2026-05-260.24x
2026-05-220.24x
2026-05-210.24x
2026-05-200.24x
2026-05-190.24x
2026-05-180.25x
2026-05-150.24x
2026-05-140.24x
2026-05-130.24x
2026-05-120.23x
2026-05-110.23x
2026-05-080.24x
2026-05-070.24x
2026-05-060.25x
2026-05-050.26x
2026-05-040.27x
2026-05-010.27x
2026-04-300.27x
2026-04-290.27x
2026-04-280.27x
2026-04-270.27x
2026-04-240.27x
2026-04-230.27x
2026-04-220.27x
2026-04-210.28x
2026-04-200.28x
2026-04-170.28x
2026-04-160.28x
2026-04-150.28x
2026-04-140.28x
2026-04-130.28x
2026-04-100.28x
2026-04-090.29x
2026-04-080.29x
2026-04-070.28x
2026-04-060.28x
2026-04-020.29x
2026-04-010.29x
2026-03-310.28x
2026-03-300.28x
2026-03-270.28x
2026-03-260.28x
2026-03-250.29x
2026-03-240.29x
2026-03-230.29x
2026-03-200.29x
2026-03-190.29x
2026-03-180.30x
2026-03-170.31x
2026-03-160.31x
2026-03-130.31x
2026-03-120.31x
2026-03-110.30x
2026-03-100.30x
2026-03-090.31x
2026-03-060.30x
2026-03-050.30x
2026-03-040.32x
2026-03-030.32x
2026-03-020.32x
2026-02-270.32x
2026-02-260.32x
2026-02-250.31x
2026-02-240.31x
2026-02-230.31x
2026-02-200.31x
2026-02-190.31x
2026-02-180.31x
2026-02-170.31x
2026-02-130.30x
2026-02-120.30x
2026-02-110.31x
2026-02-100.30x
2026-02-090.31x
2026-02-060.31x
2026-02-050.31x
2026-02-040.27x
2026-02-030.29x
2026-02-020.29x
2026-01-300.28x
2026-01-290.28x
2026-01-280.28x
2026-01-270.28x
2026-01-260.28x
2026-01-230.28x
2026-01-220.28x
2026-01-210.28x
2026-01-200.28x
2026-01-160.28x
2026-01-150.29x
2026-01-140.28x
2026-01-130.28x
2026-01-120.28x
2026-01-090.28x
2026-01-080.28x
2026-01-070.28x
2026-01-060.28x
2026-01-050.28x
2026-01-020.28x
2025-12-310.28x
2025-12-300.28x
2025-12-290.28x
2025-12-260.28x
2025-12-240.28x
2025-12-230.28x
2025-12-220.28x
2025-12-190.28x
2025-12-180.28x
2025-12-170.27x
2025-12-160.27x
2025-12-150.28x
2025-12-120.28x
2025-12-110.28x
2025-12-100.28x
2025-12-090.27x
2025-12-080.27x
2025-12-050.27x
2025-12-040.28x
2025-12-030.27x
2025-12-020.28x
2025-12-010.29x
2025-11-280.30x
2025-11-260.30x
2025-11-250.30x
2025-11-240.29x
2025-11-210.29x
2025-11-200.29x
2025-11-190.29x
2025-11-180.29x
2025-11-170.29x
2025-11-140.29x
2025-11-130.29x
2025-11-120.28x
2025-11-110.29x
2025-11-100.29x
2025-11-070.29x
2025-11-060.29x
2025-11-050.29x
2025-11-040.30x
2025-11-030.29x
2025-10-310.29x
2025-10-300.29x
2025-10-290.29x
2025-10-280.29x
2025-10-270.29x
2025-10-240.29x
2025-10-230.28x
2025-10-220.28x
2025-10-210.28x
2025-10-200.28x
2025-10-170.28x
2025-10-160.28x
2025-10-150.28x
2025-10-140.28x
2025-10-130.28x
2025-10-100.27x
2025-10-090.27x
2025-10-080.27x
2025-10-070.27x
2025-10-060.27x
2025-10-030.27x
2025-10-020.27x
2025-10-010.27x
2025-09-300.28x
2025-09-290.27x
2025-09-260.27x
2025-09-250.26x
2025-09-240.27x
2025-09-230.27x
2025-09-220.25x
2025-09-190.25x
2025-09-180.25x
2025-09-170.25x
2025-09-160.25x
2025-09-150.25x
2025-09-120.26x
2025-09-110.26x
2025-09-100.25x
2025-09-090.25x
2025-09-080.25x
2025-09-050.25x
2025-09-040.25x
2025-09-030.25x
2025-09-020.25x
2025-08-290.25x
2025-08-280.25x
2025-08-270.25x
2025-08-260.25x
2025-08-250.25x
2025-08-220.25x
2025-08-210.25x
2025-08-200.25x
2025-08-190.24x
2025-08-180.24x
2025-08-150.24x
2025-08-140.24x
2025-08-130.24x
2025-08-120.24x
2025-08-110.24x
2025-08-080.24x
2025-08-070.24x
2025-08-060.25x
2025-08-050.25x
2025-08-040.25x
2025-08-010.25x
2025-07-310.25x
2025-07-300.26x
2025-07-290.25x
2025-07-280.25x
2025-07-250.25x
2025-07-240.25x
2025-07-230.26x
2025-07-220.25x
2025-07-210.25x
2025-07-180.25x
2025-07-170.25x
2025-07-160.26x
2025-07-150.25x
2025-07-140.26x
2025-07-110.25x
2025-07-100.26x
2025-07-090.26x
2025-07-080.26x
2025-07-070.26x
2025-07-030.26x
2025-07-020.25x
2025-07-010.26x
2025-06-300.26x
2025-06-270.26x
2025-06-260.26x
2025-06-250.26x
2025-06-240.26x
2025-06-230.26x
2025-06-200.26x
2025-06-180.26x
2025-06-170.26x
2025-06-160.26x
2025-06-130.26x
2025-06-120.26x
2025-06-110.26x
2025-06-100.25x
2025-06-090.25x
2025-06-060.25x

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

Related Metrics

EV/EBITDAP/S RatioRevenueAll Metrics

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Irving, TX
44,000 employees
www.mckesson.com
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Brian S. Tyler
View full financials